Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. arterial blood
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Arterial Blood Articles & Analysis

23 news found

Revolutionising Cardiovascular Health: Monitoring the Surface Metallurgy of Stents

Revolutionising Cardiovascular Health: Monitoring the Surface Metallurgy of Stents

Surgical stents, wireframe scaffolds typically laser-cut from stainless steel, play a vital role in holding narrowed arteries open, ensuring blood flows unimpeded through the body’s vital pathways. ...

ByHiden Analytical Ltd.


£1.1 million project to develop new biodegradable stents

£1.1 million project to develop new biodegradable stents

Severe peripheral vascular disease (PVD) is caused by the formation of blockages in arteries, which reduces blood supply to the brain, heart, kidneys and limbs causing strokes, heart attacks, kidney failure and limb amputations. ...

ByArterius Limited


Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial

Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial

These positive changes observed in blood markers of oxygen utilization results in the Altitude Trial suggest TSC may enhance oxygen availability at the cellular level. ...

ByCervoMed


Rivaroxaban (Xarelto) approved in Japan for patients with peripheral artery disease (PAD) after revascularisation

Rivaroxaban (Xarelto) approved in Japan for patients with peripheral artery disease (PAD) after revascularisation

The Ministry of Health, Labor and Welfare in Japan has approved the use of the oral Factor Xa inhibitor rivaroxaban (Xarelto™) (2.5 mg twice daily, used in combination with aspirin 81-100 mg once daily) to treat patients with peripheral artery disease (PAD) after revascularization. The approval is based on data from the Phase III VOYAGER PAD trial. ...

ByBayer AG


Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE Transcarotid Stent System

Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE Transcarotid Stent System

” About Silk Road Medical’s TCAR Procedure with the ENROUTE Transcarotid Neuroprotection and Stent System TransCarotid Artery Revascularization is our clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. ...

BySilk Road Medical, Inc.


World Thrombosis Day

World Thrombosis Day

Thrombosis keys facts Thrombosis is the formation of potentially life-threatening blood clots in arteries (arterial thrombosis) or veins (venous thrombosis). The severity of thrombosis comes from the obstruction of the blood flow in organs. Thrombosis is the often preventable disorder that underlies pathology the three major ...

ByEmosis Diagnostics SAS


First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting

First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting

The presentation: Expansion of Transcarotid Artery Revascularization to Standard Risk Patients for Treatment of Carotid Artery Stenosis, will be shared by Dr. ...

BySilk Road Medical, Inc.


Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region

Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region

” About TCAR with the ENROUTE Transcarotid Neuroprotection and Stent System TCAR (TransCarotid Artery Revascularization) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. ...

BySilk Road Medical, Inc.


The Ultimate List of Attractive MedTech M&A Targets

The Ultimate List of Attractive MedTech M&A Targets

The device is used in a minimally invasive procedure with the goal of deactivating the nerves surrounding the renal arteries and thereby reducing blood pressure. In 2020, the Journal of the American College of Cardiology: Cardiovascular Interventions published six-month results from a European multicenter post-market study demonstrating the safety and efficacy of ...

ByAnuncia Medical, Inc.


Robocath successfully completes first robotic coronary angioplasties in Belgium

Robocath successfully completes first robotic coronary angioplasties in Belgium

This procedure consists in revascularizing the cardiac muscle, by inserting one or more implants (stents) into the arteries that supply it with blood. R-One is the first solution developed by Robocath. ...

ByRobocath


Study Published in JAMA Finds Hospital Availability of TCAR Associated with an Improvement in Overall Outcomes for Carotid Revascularization

Study Published in JAMA Finds Hospital Availability of TCAR Associated with an Improvement in Overall Outcomes for Carotid Revascularization

doi=10.1001/jamanetworkopen.2020.37885 About TCAR with the ENROUTE Transcarotid Neuroprotection and Stent System TCAR (TransCarotid Artery Revascularization) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. ...

BySilk Road Medical, Inc.


Study Finds MediPines’ Breakthrough Non-invasive Gas Exchange Method Highly Precise: Ideal for Covid Response

Study Finds MediPines’ Breakthrough Non-invasive Gas Exchange Method Highly Precise: Ideal for Covid Response

Published in the American Journal of Physiology Lung Cellular and Molecular Physiology, the study, entitled “Measuring the Efficiency of Pulmonary Gas Exchange Using Expired Gas Instead of Arterial Blood: Comparing the “Ideal” PO2 of Riley with End-Tidal PO2,” demonstrates the reliability and validity of a non-invasive breath-based method ...

ByMediPines


ELIXIR MEDICAL ANNOUNCES OUTSTANDING 24-MONTH DATA FOR DYNAMX CORONARY BIOADAPTOR SYSTEM, DEMONSTRATING STRONG SAFETY WITH NO TARGET LESION REVASCULARIZATION, MYOCARDIAL INFARCTION OR THROMBOSIS THROUGH 24 MONTHS

ELIXIR MEDICAL ANNOUNCES OUTSTANDING 24-MONTH DATA FOR DYNAMX CORONARY BIOADAPTOR SYSTEM, DEMONSTRATING STRONG SAFETY WITH NO TARGET LESION REVASCULARIZATION, MYOCARDIAL INFARCTION OR THROMBOSIS THROUGH 24 MONTHS

Colombo said, “Coronary arteries naturally have the ability to expand with disease progression in order to maintain blood flow to the heart. ...

ByElixir Medical Corporation


1 out of 10 survive cardiac arrest, a new device under FDA review hopes to change that

1 out of 10 survive cardiac arrest, a new device under FDA review hopes to change that

This replaces about a third of the blood flow in the body and compressions prolong the life of a patient for about 30 minutes. This small window and lack of blood can ultimately cause brain damage and even death. The Neurescue device can double the amount of time for a physician to control blood loss and increase the opportunity for ...

ByNeurescue


MagicTouch SCB Granted ‘Breakthrough Device Designation’ for the treatment of Small Coronary Artery Lesions.

MagicTouch SCB Granted ‘Breakthrough Device Designation’ for the treatment of Small Coronary Artery Lesions.

(CMI) has been granted “Breakthrough Device Designation” from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the MagicTouch SCB Sirolimus Coated Balloon Catheter, for the treatment of small coronary artery lesions in Coronary Artery Disease (CAD). The proposed indication for use includes “The ...

ByConcept Medical Inc.


Ground-breaking New Medical Device Saving Lives and Resources During Pandemic

Ground-breaking New Medical Device Saving Lives and Resources During Pandemic

Doctors can use the AGM100® to continue to monitor lung function at a micro level without having to perform blood tests. This allows for better therapies and reduced dependence on hospital labs. ...

ByMediPines


Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Actelion is a leader in the science and treatment of pulmonary arterial hypertension (PAH), a long-term, life-threatening cardiopulmonary disorder characterized by abnormally high blood pressure within the arteries in the lungs. ...

ByThird Pole Therapeutics, Inc.


SKI Vascular Center is First Ambulatory Surgical Center in the Nation to Utilize FDA-Approved Ellipsys System for Non-Surgical Dialysis Fistula Creation

SKI Vascular Center is First Ambulatory Surgical Center in the Nation to Utilize FDA-Approved Ellipsys System for Non-Surgical Dialysis Fistula Creation

A significant advancement for dialysis patients and clinicians, the Ellipsys System, developed by Avenu Medical (San Juan Capistrano, CA), transforms an open surgery connecting an artery to a vein into a minimally invasive procedure using a needle and a catheter. ...

ByMedtronic


Amsel Medical Corporation Announces First-In-Man Clinical Use of the Amsel Occluder Device at NYU Langone Medical Center

Amsel Medical Corporation Announces First-In-Man Clinical Use of the Amsel Occluder Device at NYU Langone Medical Center

About the Amsel Occluder Device The Amsel Occluder Device is designed to easily and securely close blood vessels (veins or arteries) as well as tubular structures during open surgical procedures. ...

ByAmsel Medical Corporation


Wired: This startup wants to stop deaths from cardiac arrest?

Wired: This startup wants to stop deaths from cardiac arrest?

” During cardiac arrest, the heart starts beating with an erratic rhythm. As a result, very little blood is flowing throughout the body. Without blood supply, different organs start dying out at different rates. ...

ByNeurescue

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT